Literature DB >> 32948262

Health Care After the COVID-19 Pandemic and the Influence of Telemedicine.

Zelalem M Temesgen1, Daniel C DeSimone1, Maryam Mahmood1, Claudia R Libertin2, Bharath Raj Varatharaj Palraj1, Elie F Berbari3.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32948262      PMCID: PMC7383140          DOI: 10.1016/j.mayocp.2020.06.052

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


× No keyword cloud information.
After the first cases of coronavirus disease 2019 (COVID-19) were reported on December 31, 2019, and its causative agent, severe acute respiratory syndrome coronavirus 2 was identified, the pandemic spread to more than 212 countries, overwhelming health care systems and economies on a global scale. As of May 26, 2020, the cumulative number of confirmed cases of COVID-19 worldwide exceeded 5.4 million, and in the United States, the number of confirmed COVID-19 cases was nearly 1.7 million. The large scale of the pandemic has caused health care systems to shift how they deliver care quickly and substantially. Even more changes are anticipated as the pandemic comes under control—within health care systems and from governments and payers (Table ).
Table

Anticipated Changes to Health Care After Coronavirus Disease 2019

ChangeResult
TelemedicineImproved access to medical providersReduced costs for patients, eg, less travel, time away from workIncreased humanitarian outreach to underserved populations, including those in rural and global communities
WorkflowsDecreased waste through efficient workflowsStreamlined services
Artificial intelligenceReduced redundancies in medicine from accelerated use of artificial intelligenceRemote monitoring to predict patients who need urgent attentionOutcomes predicted for drug therapies or operations
Public health and population health programsIncreased funding for public health agencies at local and state levelsMobile tracking applications for more rapid and cost-effective contact tracing
Connected care programsRemote monitoring of vital signs and electrocardiography, reduced rehospitalizations with tracking of medications, and less morbidity and mortality
ReimbursementChanges to current obsolete reimbursement modelsCompetitive rates for telemedicine and in-person visits, allowing sustainability of health care systems
LicensureSingle licensure institutedState borders eliminated for practicing medicine
Redefining health care workersCare lines blurred between care delivered by physicians, advanced practice providers, and nurses
MalpracticeClarity brought to malpractice insurance
Anticipated Changes to Health Care After Coronavirus Disease 2019 One major shift that has already occurred is in the use of telemedicine platforms, that is, managing patient care virtually through nonphysical encounters with the use of videoconferencing and telephone communications. , These changes resulted from shrinking economies and the ongoing risk of severe acute respiratory syndrome coronavirus 2 exposure to patients and health care workers. Basic microeconomic theory explains the rapidity with which telemedicine is being adopted, that is, demand for a service outpaced the supply (physicians) and was associated with rising costs and risks to patients and to health care workers providing that care. With the anticipated future shortage of providers, we believe that video-based remote consultations will change health care delivery long after COVID-19. At Mayo Clinic, the sudden and unanticipated disruption of the health care delivery model caused by COVID-19 resulted in telemedicine’s being accepted by health care professionals and patients, and this new model of care will likely be fully integrated into our health care delivery platform within the next few years. Telemedicine has allowed for continued patient care while ensuring the safety of patients and health care workers during the crisis. This was made possible largely through the relaxation of regulatory and licensure barriers that existed before the pandemic. These barriers included lack of adequate reimbursement for telemedicine visits and varying, costly, and cumbersome state requirements for licensure. There is a great expectation that these relaxed telemedicine regulations will continue after the COVID-19 crisis is over, which will be a welcome development as telemedicine adds another dimension to providing health care that is efficient and cost beneficial for patients and for health care systems. Patients’ long-term satisfaction with this new care delivery model will be driven by ongoing safety concerns related to in-person care and by logistical considerations related to travel to destination centers. Chronic conditions require repeated encounters with the health care system, which inconveniences patients and may lead to increased costs of care, missing appointments, and nonadherence to treatment plans. Telehealth provides an opportunity to maintain and to enhance these encounters in ways that will be more acceptable to patients. For health care systems, telemedicine will become a force multiplier, given its ability to scale care, improve the efficiency of workflows, and expand provider reach to underserved areas, including rural or geographically isolated populations globally. With telemedicine, in-home care can be delivered that can ensure patients comply with care plans, thus decreasing the risk of hospitalizations and consequences including cost, hospital-acquired infections, and the potential for antimicrobial drug resistance. Effective in-home care will also hopefully translate into improved care for older adults, with less disruption of family and social lives, including the inconvenience of getting to appointments for those who no longer drive and time away from work for family members caring for older relatives. In addition, the availability of telemedicine will encourage people to seek medical evaluation earlier in an illness, thus avoiding the consequences of late diagnosis and treatment that would be detrimental to their health and finances as well as to the health care system. The expansion of telemedicine will accelerate technology-based solutions for telehealth, including remote monitoring of vital signs and acquisition of other health data in real time, thus enabling timely diagnosis and prompt initiation of treatment. Designation of new workflows enhanced by artificial intelligence will support an integrated transition between virtual and in-person care. Issues of privacy, disclosures, interoperability of electronic health records, and data security will need continued scrutiny and updating as telehealth expands. The rapid increase and wide adaptation of telemedicine into care delivery models should be balanced against the perception by some patients and providers of its safety and value compared with in-person care. A concern exists that telemedicine may be viewed by health care providers as an erosion of the empathic physician-patient relationship that might result in depersonalization of care. To enhance utilization of telemedicine, it will be critical to identify and categorize conditions, acuity, and temporal relationships to care (eg, initial or follow-up visits) that could be optimally served by telehealth methods. Effective and efficient virtual care will require a reliable communication infrastructure and affordable and readily accessible broadband connectivity to rural regions, which could close one of the health disparity gaps in our country as well as allow for global outreach and national programs for all underserved populations. In conclusion, a number of driving forces will influence health care in the United States during and after the COVID-19 pandemic. During the pandemic, telemedicine has had an important role in health care delivery, allowing for ongoing medical care while ensuring the safety of patients and health care workers. This situation occurred only after local and federal regulations surrounding telemedicine were relaxed. If these relaxed regulations continue, the promise of expanded access, improved efficiencies, and enhanced patient outcomes also continues. Telemedicine is a means to developing an organization’s ability to provide in-home quality care, thus lowering health care costs and bridging health care access to underserved populations. Careful planning, continued scrutiny, and adaptation of existing methods are urgently needed to further increase the adoption of telemedicine into routine clinical care.
  3 in total

1.  Global supply of health professionals.

Authors:  Nigel Crisp; Lincoln Chen
Journal:  N Engl J Med       Date:  2014-03-06       Impact factor: 91.245

2.  Virtual health care in the era of COVID-19.

Authors:  Paul Webster
Journal:  Lancet       Date:  2020-04-11       Impact factor: 79.321

3.  Telehealth for global emergencies: Implications for coronavirus disease 2019 (COVID-19).

Authors:  Anthony C Smith; Emma Thomas; Centaine L Snoswell; Helen Haydon; Ateev Mehrotra; Jane Clemensen; Liam J Caffery
Journal:  J Telemed Telecare       Date:  2020-03-20       Impact factor: 6.184

  3 in total
  28 in total

1.  Depression, HIV, and COVID-19: A Deadly Trifecta.

Authors:  David May; Robert Fullilove
Journal:  Public Health Rep       Date:  2022-02-09       Impact factor: 3.117

Review 2.  Cardiac rehabilitation in older adults: Apropos yet significantly underutilized.

Authors:  Andrew H Lutz; Daniel E Forman
Journal:  Prog Cardiovasc Dis       Date:  2022-01-10       Impact factor: 11.278

3.  Multiple Sclerosis Patient Management During the COVID-19 Pandemic: Practical Recommendations From the Portuguese Multiple Sclerosis Study Group (GEEM).

Authors:  João J Cerqueira; Ana F Ladeira; Ana M Silva; Ângela Timóteo; José Vale; Lívia Sousa; Marta Arenga; Pedro Abreu; Rui Guerreiro; João de Sá
Journal:  Front Neurol       Date:  2021-03-08       Impact factor: 4.003

4.  Provider Evaluation of a Novel Virtual Hybrid Hospital at Home Model.

Authors:  Michael J Maniaci; Karla Maita; Ricardo A Torres-Guzman; Francisco R Avila; John P Garcia; Abdullah Eldaly; Antonio J Forte; Gautam V Matcha; Ricardo J Pagan; Margaret R Paulson
Journal:  Int J Gen Med       Date:  2022-02-22

5.  Impact of the COVID-19 pandemic on head and neck cancer diagnosis: data from a single referral center, South Tyrol, northern Italy.

Authors:  Luca Gazzini; Enrico Fazio; Virginia Dallari; Remo Accorona; Monir Abousiam; Aurel Nebiaj; Giovanni Giorgetti; Ilaria Girolami; Fabio Vittadello; Roberto Magnato; Martin Patscheider; Guido Mazzoleni; Luca Calabrese
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-11-05       Impact factor: 2.503

6.  Association of a Remote Patient Monitoring (RPM) Program With Reduced Hospitalizations in Cancer Patients With COVID-19.

Authors:  Joshua C Pritchett; Bijan J Borah; Aakash P Desai; Zhuoer Xie; Antoine N Saliba; Konstantinos Leventakos; Jordan D Coffey; Kristina K Pearson; Leigh L Speicher; Robert Orenstein; Abinash Virk; Ravindra Ganesh; Jonas Paludo; Thorvardur R Halfdanarson; Tufia C Haddad
Journal:  JCO Oncol Pract       Date:  2021-06-04

7.  Preventing the Next Pandemic: The Case for Investing in Circulatory Health - A Global Coalition for Circulatory Health Position Paper.

Authors:  Leslie Rae Ferat; Ryan Forrest; Kawaldip Sehmi; Raul D Santos; David Stewart; Andrew J M Boulton; Beatriz Yáñez Jiménez; Phil Riley; Dylan Burger; Erika S W Jones; Maciej Tomaszewski; Maria Rita Milanese; Paul Laffin; Vivekanand Jha; Bettina Borisch; Michael Moore; Fausto J Pinto; Daniel Piñeiro; Jean-Luc Eiselé; Daniel T Lackland; Paul K Whelton; Xin-Hua Zhang; Anna Stavdal; Donald Li; Richard Hobbs; Jeyaraj Durai Pandian; Michael Brainin; Valery Feigin
Journal:  Glob Heart       Date:  2021-10-12

8.  Smartphone-based remote monitoring of vision in macular disease enables early detection of worsening pathology and need for intravitreal therapy.

Authors:  Meriam Islam; Stafford Sansome; Radha Das; Marko Lukic; Kelvin Yi Chong Teo; Gavin Tan; Konstantinos Balaskas; Peter B M Thomas; Lucas M Bachmann; Andrew M Schimel; Dawn A Sim
Journal:  BMJ Health Care Inform       Date:  2021-05

9.  Telemedicine Across the Globe-Position Paper From the COVID-19 Pandemic Health System Resilience PROGRAM (REPROGRAM) International Consortium (Part 1).

Authors:  Sonu Bhaskar; Sian Bradley; Vijay Kumar Chattu; Anil Adisesh; Alma Nurtazina; Saltanat Kyrykbayeva; Sateesh Sakhamuri; Sanni Yaya; Thankam Sunil; Pravin Thomas; Viviana Mucci; Sebastian Moguilner; Simon Israel-Korn; Jason Alacapa; Abha Mishra; Shawna Pandya; Starr Schroeder; Ashish Atreja; Maciej Banach; Daniel Ray
Journal:  Front Public Health       Date:  2020-10-16

Review 10.  Tele-neuro-oncology: Current Practices and Future Directions.

Authors:  Andrea Wasilewski; Nimish Mohile
Journal:  Curr Oncol Rep       Date:  2022-01-20       Impact factor: 5.945

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.